Northwestern University researchers have uncovered how ketamine delivers rapid and prolonged depression relief by activating new neurons for immediate effects and increasing their production for lasting benefits. This breakthrough could lead to safer, ketamine-inspired antidepressants.
A recent study delves into how consecutive nights of alcohol consumption before sleep alter sleep architecture, revealing increased deep sleep early on but reduced REM sleep and more disturbances later. This nuanced insight highlights the body's adaptation over time, underscoring...
MDMA enhances positive responses to social feedback without affecting negative responses. This sheds light on MDMA's potential in treating social processing impairments, spotlighting its unique empathogenic effects.
Studies reveal over 50% of ayahuasca users experience a personal death phenomenon, profoundly altering beliefs on consciousness and environmental concerns. These insights, derived from two studies, highlight the psychedelic's impact on spiritual growth and attitudes towards life and death.
A study published in Nature Communications found that SSRIs like fluoxetine can affect early brain development, altering connections in the prefrontal cortex. The research, using rodents, highlights serotonin's crucial role in brain maturation.
Can cannabis offer a lifeline in the battle against drug addiction, particularly for those grappling with the perils of stimulants like crystal methamphetamine? New research from the University of British Columbia (UBC) suggests it might.
A recent study explores psilocybin's effects on larval zebrafish, revealing it enhances exploratory behavior and buffers stress-induced activity changes, offering insights into psychedelic compounds' potential in mental health treatment.
DMT, a psychedelic, reduced depression symptoms in a study with experienced volunteers. The stronger the DMT experience, the greater the mental health benefits observed. However, results for anxiety and well-being were mixed, suggesting more research is needed to fully understand...
New research has found a connection between cannabis use during adolescence and decreased chances of completing higher education in adulthood. The findings have been published in Economics & Human Biology.
In work recently published in the Journal of Psychopharmacology, scientists have breathed new life into a decades-old tool for understanding the psychedelic experience, expanding our grasp of these profound states of mind. By reviving and updating the Psychedelic Experience Scale,...
SSRIs like escitalopram may boost brain plasticity, potentially aiding in depression treatment by enhancing neural adaptability and communication. Novel treatments like intranasal esketamine and psychedelics target different brain receptors, suggesting diverse mechanisms of action. Understanding these processes is crucial for...
Can groundbreaking treatments for depression and other psychiatric conditions come from substances once considered purely recreational or even taboo? A recent study by researchers at Johns Hopkins Medicine suggests the answer may be yes.
Interviews with clinicians reveal potential benefits of MDMA-assisted therapy for Borderline Personality Disorder (BPD), suggesting similarities with PTSD treatment. The study, published in the Journal of Psychedelic Studies, calls for further research into MDMA's efficacy for BPD.
A recent study published in the journal Addictive Behaviors reveals significant insights into how cannabis consumption among teenagers could impact their cognitive development, particularly in areas related to memory and attention. The research suggests that even light to moderate cannabis...
New research suggests that psychedelics like LSD and psilocybin increase unusual visual phenomena, such as seeing with open eyes patterns or objects that are not actually present.